Target intelligence / Profile preview

Greater splanchnic nerve (sympathetic nervous system signaling)

Molecular classification
Other (nerve, not a molecule or receptor)
01

Overview

The **greater splanchnic nerve** is a major sympathetic nerve arising from the medial branches of the fifth to ninth thoracic sympathetic ganglia. It carries preganglionic sympathetic fibers that pass through the diaphragm and terminate primarily in the celiac ganglion, where they synapse with postganglionic neurons. These postganglionic fibers then innervate foregut organs such as the liver, stomach, pancreas, spleen, and upper duodenum. The greater splanchnic nerve also sends some fibers directly to the adrenal medulla to stimulate catecholamine release. Its main function is to regulate autonomic control over abdominal visceral functions including blood flow distribution and modulation of digestive activity[1][3][5][7]. **Note:** This entry describes a *nerve*—a bundle of axons mediating signaling—not a molecular therapeutic target such as a receptor, enzyme, transporter, or ion channel. Therefore: - **is_target:** false — The greater splanchnic nerve itself is not considered a druggable molecular target. - **is_incorrect:** true — "Sympathetic nervous system signaling via greater splanchnic nerve" refers to an anatomical/physiological pathway rather than an individual molecule/receptor suitable for structured drug-target databases. If you are seeking information on specific molecular targets within this pathway (e.g., adrenergic receptors), those should be specified individually by their canonical names.

Other names
Greater thoracic splanchnic nerveThoracic splanchnic nerve (when referring specifically to the greater branch)
02

Biological functions

Sympathetic innervation of abdominal visceraRegulation of visceral blood flow and digestive processes[1][3][7]
03

Disease associations

Other (may be involved in autonomic dysfunctions, but not a direct disease target)
04

Safety considerations

Surgical or procedural injury may cause autonomic dysfunction or pain syndromes[1]

Beyond the preview

Go deeper on Greater splanchnic nerve (sympathetic nervous system signaling).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Greater splanchnic nerve (sympathetic nervous system signaling).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call